Cargando…
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)
BACKGROUND: Acute Coronary Syndromes account for 15% of deaths in the UK, and patients remain at significant risk of re-admission for future complications and death. Pathologically the underlying process of atherosclerosis is driven by inflammatory mechanisms, which are activated in ACS patients. Pr...
Autores principales: | Crossman, David C, Morton, Allison C, Gunn, Julian P, Greenwood, John P, Hall, Alistair S, Fox, Keith AA, Lucking, Andrew J, Flather, Marcus D, Lees, Belinda, Foley, Claire E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289802/ https://www.ncbi.nlm.nih.gov/pubmed/18298837 http://dx.doi.org/10.1186/1745-6215-9-8 |
Ejemplares similares
-
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
por: Morton, Allison C., et al.
Publicado: (2015) -
The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
por: Smith, G. S., et al.
Publicado: (1996) -
Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts
por: Palmer, G, et al.
Publicado: (2003) -
Turangal{circ}ila-symphonie
por: Messiaen, Olivier, 1908-
Publicado: (1991) -
The Experimental Treatment of Corneal Graft Rejection with the Interleukin-1 Receptor Antagonist (IL-1ra) Gene
por: Yuan, Jin, et al.
Publicado: (2013)